ALLO icon

Allogene Therapeutics
ALLO

Overview Fund Activity

173 hedge funds and large institutions have $402M invested in Allogene Therapeutics in 2024 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 62 increasing their positions, 42 reducing their positions, and 14 closing their positions.

Holders
173
Holders Change
+18
Holders Change %
+11.61%
% of All Funds
2.3%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
32
Increased
62
Reduced
42
Closed
14
Calls
$446K
Puts
$176K
Net Calls
+$270K
Net Calls Change
+$315K

Top Buyers

1
P
1
Pfizer
New York
$46.9M
2
LCM
2
Lynx1 Capital Management
Puerto Rico
$23.2M
3
FCMV
3
Foresite Capital Management VI
California
$7.34M
4
PSC
4
Patient Square Capital
California
$3.17M
5
GS
5
Gilead Sciences
California
$2.46M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$50.6M
2
PA
2
Perceptive Advisors
New York
$0
3
ECM
3
ExodusPoint Capital Management
New York
$0
4
Primecap Management
4
Primecap Management
California
$10.5M
5
Morgan Stanley
5
Morgan Stanley
New York
$2.13M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$50.6M 23,771,995 -6,254,961 -21%
P
2
Pfizer
New York
$46.9M 22,032,040 +22,032,040 New
TGA
3
TPG GP A
Texas
$39.9M 18,716,306 – –
BlackRock
4
BlackRock
New York
$38.5M 18,062,655 +289,910 +2%
LCM
5
Lynx1 Capital Management
Puerto Rico
$23.2M 10,874,723 +4,672,349 +75%
Vanguard Group
6
Vanguard Group
Pennsylvania
$17M 8,000,692 -327,007 -4%
State Street
7
State Street
Massachusetts
$15.4M 7,249,966 +236,883 +3%
Capital World Investors
8
Capital World Investors
California
$14.7M 6,896,552 – –
Citadel Advisors
9
Citadel Advisors
Florida
$11.4M 5,349,096 +309,502 +6%
Primecap Management
10
Primecap Management
California
$10.5M 4,927,340 -740,920 -13%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$9.56M 4,485,572 -353,171 -7%
WP
12
Woodline Partners
California
$9.29M 4,360,232 -4,068 -0.1%
JPMorgan Chase & Co
13
JPMorgan Chase & Co
New York
$7.96M 3,736,132 -351,374 -9%
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$7.59M 3,561,626 +831,146 +30%
FCMV
15
Foresite Capital Management VI
California
$7.34M 3,448,275 +3,448,275 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$6.89M 3,232,618 +5,514 +0.2%
WCM
17
Wildcat Capital Management
New York
$6.22M 2,920,787 – –
FLSM
18
Frazier Life Sciences Management
California
$6.11M 2,867,750 – –
Two Sigma Investments
19
Two Sigma Investments
New York
$5.78M 2,712,139 -85,831 -3%
Two Sigma Advisers
20
Two Sigma Advisers
New York
$5.76M 2,702,200 +291,800 +12%
Goldman Sachs
21
Goldman Sachs
New York
$4.49M 2,106,577 -56,026 -3%
VVA
22
Vida Ventures Advisors
Massachusetts
$3.83M 1,798,163 – –
VPC
23
Vestal Point Capital
New York
$3.2M 1,500,000 – –
PSC
24
Patient Square Capital
California
$3.17M 1,489,909 +1,489,909 New
Northern Trust
25
Northern Trust
Illinois
$2.78M 1,305,232 +56,693 +5%
1
2 3 4 5